AI Science Tracker

Department of Medicine, Service of Immunology and Allergy, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

1 discovery from 2024

Discoveries

RAIN: machine learning-based identification for HIV-1 bNAbs

Source check: Needs source check. Not independent scientific confirmation.

Finding: RAIN: machine learning-based identification for HIV-1 bNAbs. RAIN classifies HIV-1 bNAbs from BCR repertoire sequences, leading to identification of CD4-binding-site bNAbs. Identified antibodies were validated in an in vitro neutralization assay and one was solved by single-particle cryo-EM in complex with Env. Evidence limits: Number of donors and false-positive rate not assessed (abstract only); no in vivo or clinical test. Reviewed from Europe PMC abstract only.

Technology: RAIN, machine-learning classifier on sequence-based antibody features

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
RAIN classifies HIV-1 bNAbs from BCR repertoire sequences, leading to identification of CD4-binding-site bNAbs.
Test and result
Identified antibodies were validated in an in vitro neutralization assay and one was solved by single-particle cryo-EM in complex with Env.
Limitation / still unknown
Number of donors and false-positive rate not assessed (abstract only); no in vivo or clinical test.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://europepmc.org/article/MED/38914562

Needs source check · editorial details

The source has not been fully checked or contains conflicting information. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review scope and date are not recorded; source checked does not establish full-text review.

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.